Jazz Pharmaceuticals (JAZZ)
(Real Time Quote from BATS)
$109.33 USD
-1.43 (-1.29%)
Updated Sep 23, 2024 12:14 PM ET
3-Hold of 5 3
A Value B Growth C Momentum A VGM
- YR Estimate
- 12/31/2023
- 12/31/2022
- 12/31/2021
- 12/31/2020
- 12/31/2019
- Revenue - Line of Business (LOBR)
- Revenues: Product sales, net
- 3,736.94
- 3,641.43
- 3,079.00
- 2,346.66
- 2,135.60
- Revenue - Line of Business (LOBR)
- Revenues: Royalties and contract revenues
- 97.26
- 17.95
- 15.24
- 16.91
- 26.16
- Revenue - Line of Business (LOBR)
- Total revenues: Neuroscience: Oxybate: Xywav
- 1,272.98
- 958.43
- 535.30
- 15.26
- --
- Revenue - Line of Business (LOBR)
- Total revenues: Neuroscience: Oxybate: Xyrem
- 569.73
- 1,020.45
- 1,265.83
- 1,741.76
- 1,642.53
- Revenue - Line of Business (LOBR)
- Total revenues: Neuroscience: Oxybate (Xywav & Xyrem)
- 1,842.71
- 1,978.88
- 1,801.13
- 1,757.02
- 1,642.53
- Revenue - Line of Business (LOBR)
- Total revenues: Neuroscience: Epidiolex/Epidyolex
- 845.47
- 736.40
- 463.65
- --
- --
- Revenue - Line of Business (LOBR)
- Total revenues: Neuroscience: Sativex
- 19.67
- 16.83
- 12.71
- --
- --
- Revenue - Line of Business (LOBR)
- Total revenues: Neuroscience: Total
- 2,707.84
- 2,760.95
- 2,335.39
- 1,785.36
- 1,646.24
- Revenue - Line of Business (LOBR)
- Total revenues: Oncology: Rylaze
- 394.23
- 281.66
- 85.63
- --
- --
- Revenue - Line of Business (LOBR)
- Total revenues: Oncology: Zepzelca
- 289.53
- 269.91
- 246.81
- 90.38
- --
- Revenue - Line of Business (LOBR)
- Total revenues: Oncology: Defitelio/defibrotide
- 184.00
- 194.29
- 197.93
- 195.84
- 172.94
- Revenue - Line of Business (LOBR)
- Total revenues: Oncology: Vyxeos
- 147.50
- 127.98
- 134.06
- 121.11
- 121.41
- Revenue - Line of Business (LOBR)
- Total revenues: Other
- 13.85
- 6.64
- 9.80
- 6.84
- 17.55
- Revenue - Line of Business (LOBR)
- Total revenues: Other royalty and contract revenues
- 21.34
- --
- --
- --
- --
- Revenue - Line of Business (LOBR)
- Total revenues: High-sodium oxybate AG royalty revenue
- 75.92
- --
- --
- --
- --
- Revenue - Line of Business (LOBR)
- Total revenues: Oncology: Total
- 1,015.25
- 873.84
- 733.81
- 554.46
- 471.81
- Revenue - Geographic (GEOR)
- Geographic revenues: United States
- 3,489.98
- 3,370.38
- 2,820.24
- 2,144.54
- 1,964.16
- Revenue - Geographic (GEOR)
- Geographic revenues: Europe
- 269.24
- 239.64
- 230.16
- 175.21
- 150.20
- Revenue - Geographic (GEOR)
- Geographic revenues: All other regions
- 74.98
- 49.36
- 43.84
- 43.82
- 47.40